94 related articles for article (PubMed ID: 28277344)
1. Use of Hydroxychloroquine Is Associated With Improved Lipid Profile in Rheumatoid Arthritis Patients.
Restrepo JF; Del Rincon I; Molina E; Battafarano DF; Escalante A
J Clin Rheumatol; 2017 Apr; 23(3):144-148. PubMed ID: 28277344
[TBL] [Abstract][Full Text] [Related]
2. Hydroxychloroquine use is associated with reduced mortality risk in older adults with rheumatoid arthritis.
Iyer P; Gao Y; Jalal D; Girotra S; Singh N; Vaughan-Sarrazin M
Clin Rheumatol; 2024 Jan; 43(1):87-94. PubMed ID: 37498463
[TBL] [Abstract][Full Text] [Related]
3. Hydroxychloroquine and Cardiovascular Events in Patients with Rheumatoid Arthritis.
Cordova Sanchez A; Khokhar F; Olonoff DA; Carhart RL
Cardiovasc Drugs Ther; 2024 Apr; 38(2):297-304. PubMed ID: 36197529
[TBL] [Abstract][Full Text] [Related]
4. Positive effect of hydroxychloroquine on lipid profiles of patients with rheumatoid arthritis: A Veterans Affair cohort.
Guevara M; Ng B
Eur J Rheumatol; 2021 Apr; 8(2):62-66. PubMed ID: 33164740
[TBL] [Abstract][Full Text] [Related]
5. Clinical and immunological effects of hydroxychloroquine in patients with active rheumatoid arthritis despite antirheumatic treatment.
Takei H; Takanashi S; Otomo K; Hanaoka H; Kikuchi J; Yamaoka K; Yoshimoto K; Abe T; Takeuchi T; Kaneko Y
Mod Rheumatol; 2023 Dec; 34(1):50-59. PubMed ID: 36484525
[TBL] [Abstract][Full Text] [Related]
6. Hydroxychloroquine had neutral effect on long-term risk of malignancy in rheumatoid arthritis patients: A population-based retrospective cohort study.
Hou XJ; Chang R; Wang YH; Kang TL; Wei JC
Int J Rheum Dis; 2024 Mar; 27(3):e15102. PubMed ID: 38450839
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis and preliminary laboratory validation of treatment efficacy and blood lipid levels in patients with rheumatoid arthritis.
Wang Y; Xie H; Huang X; Chen K; Zhu Y; Yao G
Clin Rheumatol; 2023 Dec; 42(12):3213-3223. PubMed ID: 37488372
[TBL] [Abstract][Full Text] [Related]
8. Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study.
Lane JCE; Weaver J; Kostka K; Duarte-Salles T; Abrahao MTF; Alghoul H; Alser O; Alshammari TM; Areia C; Biedermann P; Banda JM; Burn E; Casajust P; Fister K; Hardin J; Hester L; Hripcsak G; Kaas-Hansen BS; Khosla S; Kolovos S; Lynch KE; Makadia R; Mehta PP; Morales DR; Morgan-Stewart H; Mosseveld M; Newby D; Nyberg F; Ostropolets A; Woong Park R; Prats-Uribe A; Rao GA; Reich C; Rijnbeek P; Sena AG; Shoaibi A; Spotnitz M; Subbian V; Suchard MA; Vizcaya D; Wen H; Wilde M; Xie J; You SC; Zhang L; Lovestone S; Ryan P; Prieto-Alhambra D;
Rheumatology (Oxford); 2021 Jul; 60(7):3222-3234. PubMed ID: 33367863
[TBL] [Abstract][Full Text] [Related]
9. The effects of conventional drugs in the treatment of rheumatoid arthritis on the serum lipids.
Karimifar M; Sepehrifar MS; Moussavi H; Sepehrifar MB; Mottaghi P; Siavash M; Karimifar M
J Res Med Sci; 2018; 23():105. PubMed ID: 30693040
[TBL] [Abstract][Full Text] [Related]
10. Use of Hydroxychloroquine and Risk of Heart Failure in Patients With Rheumatoid Arthritis.
Sorour AA; Kurmann RD; Shahin YE; Crowson CS; Achenbach SJ; Mankad R; Myasoedova E
J Rheumatol; 2021 Oct; 48(10):1508-1511. PubMed ID: 33452171
[TBL] [Abstract][Full Text] [Related]
11. A study to determine the effect of hydroxychloroquine (HCQ) on central corneal thickness (CCT) in patients with rheumatoid arthritis (RA).
Jaichander RC; Thomas RK; Shobha V
Indian J Ophthalmol; 2024 Feb; 72(2):270-274. PubMed ID: 38099363
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the Use of Hydroxychloroquine in Treating Patients With Rheumatoid Arthritis.
Nazir AM; Koganti B; Gupta K; Memon MS; Aslam Zahid MB; Shantha Kumar V; Tappiti M; Mostafa JA
Cureus; 2021 Nov; 13(11):e19308. PubMed ID: 34765383
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of hydroxychloroquine on rheumatoid arthritis-associated atherosclerosis.
Shi N; Zhang S; Silverman G; Li M; Cai J; Niu H
Animal Model Exp Med; 2019 Jun; 2(2):98-106. PubMed ID: 31392302
[TBL] [Abstract][Full Text] [Related]
14. Does Regular Use of a Complementary Medicine of
Bahadori S; Ahmadzadeh A; Shams Ardekani MR; Kamalinejad M; Keshavarz M; Salamzadeh J
Iran J Pharm Res; 2016; 15(4):933-940. PubMed ID: 28243292
[TBL] [Abstract][Full Text] [Related]
15. Lipids in RA: Is Less Not Necessarily More?
Plutzky J; Liao KP
Curr Rheumatol Rep; 2018 Feb; 20(2):8. PubMed ID: 29464513
[TBL] [Abstract][Full Text] [Related]
16. The effect of hydroxychloroquine on cholesterol synthesis depends on the profile of cholesterol metabolism. A controlled clinical study.
Simonen P; Ulander L; Eklund KK; Niemi M; Backman JT; Gylling H; Sinisalo J;
Atheroscler Plus; 2024 Mar; 55():93-97. PubMed ID: 38487037
[TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine and risk of development of cancers: a nationwide population-based cohort study.
Mao IC; Lin CY; Wu CL; Kor CT; Chang CC
Ther Clin Risk Manag; 2018; 14():1435-1443. PubMed ID: 30154660
[TBL] [Abstract][Full Text] [Related]
18. CYP2D6 and CYP3A4 variants influence the risk and outcome of COVID-19 infection among rheumatoid arthritis patients maintained on hydroxychloroquine.
Salem Hareedy M; Rashad SM; Hetta HF; Hassanien SM; Abdellatif H; Hassanien M
Drug Metab Pers Ther; 2021 Mar; ():. PubMed ID: 33770833
[TBL] [Abstract][Full Text] [Related]
19. A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role.
Hage MP; Al-Badri MR; Azar ST
Ther Adv Endocrinol Metab; 2014 Aug; 5(4):77-85. PubMed ID: 25343023
[TBL] [Abstract][Full Text] [Related]
20. Associations Between Genetic Variation in the Targets of Low-Density Lipoprotein-Lowering Drugs and Rheumatoid Arthritis.
Qin C; Hägg S
Circ Genom Precis Med; 2024 Feb; 17(1):e004232. PubMed ID: 38047393
[No Abstract] [Full Text] [Related]
[Next] [New Search]
